Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

WEST PHARMACEUTICAL SERVICES INC (WST) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $445.92 Metrics
OS: 73.9 M
Market cap: $32.9 B
Net cash: $794 M $10.74 per share
EV: $32.1 B

 
TTM Valuation
EBITDA $925 M 34.8 x EV/EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues2,831.62,146.91,839.91,717.41,599.11,509.11,399.81,421.4
            Revenue growth31.9%16.7%7.1%7.4%6.0%7.8%-1.5%3.9%
Cost of goods sold1,655.81,379.11,234.21,172.01,086.21,007.7944.0973.6
Gross profit1,175.8767.8605.7545.4512.9501.4455.8447.8
            Gross margin41.5%35.8%32.9%31.8%32.1%33.2%32.6%31.5%
Selling, general and administrative362.8302.0272.7262.9246.0239.6233.0228.7
Research and development52.846.938.940.339.136.834.137.3
EBITA778.5432.1313.8259.7237.4232.4137.9192.2
            EBITA margin27.5%20.1%17.1%15.1%14.8%15.4%9.9%13.5%
Amortization of intangibles5.44.43.42.72.42.63.54.9
EBIT773.1427.7310.4257.0235.0229.8134.4187.3
            EBIT margin27.3%19.9%16.9%15.0%14.7%15.2%9.6%13.2%
Pre-tax income748.9401.3291.8240.7222.4189.8116.1169.0
Income taxes107.272.559.041.480.954.426.347.2
            Tax rate14.3%18.1%20.2%17.2%36.4%28.7%22.7%27.9%
Net income661.8346.2241.7206.9150.7143.695.6127.1
            Net margin23.4%16.1%13.1%12.0%9.4%9.5%6.8%8.9%
 
Diluted EPS$8.67$4.57$3.21$2.74$1.99$1.91$1.30$1.75
Shares outstanding (diluted)76.375.875.475.475.875.073.872.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy